RDYY vs. BIB
RDYY (YieldMax RDDT Option Income Strategy ETF) and BIB (ProShares Ultra Nasdaq Biotechnology) are both exchange-traded funds - RDYY is a Derivative Income fund actively managed by YieldMax, while BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%). RDYY is actively managed, while BIB is passively managed. Their 0.18 correlation means their historical movements had little consistent relationship. RDYY charges 0.99%/yr vs 0.95%/yr for BIB.
Performance
RDYY vs. BIB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RDYY achieves a -34.23% return, which is significantly lower than BIB's 21.11% return.
RDYY
- 1D
- -18.48%
- 1M
- -23.75%
- 6M
- -17.27%
- YTD
- -34.23%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
BIB
- 1D
- -3.70%
- 1M
- -9.58%
- 6M
- 16.23%
- YTD
- 21.11%
- 1Y
- 90.29%
- 3Y*
- 23.98%
- 5Y*
- 0.36%
- 10Y*
- 6.95%
- ALL TIME*
- 17.28%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $704.96K | $1.10M | $967.78K | |
| $1.30M | $1.28M | $997.83K |
RDYY vs. BIB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
RDYY YieldMax RDDT Option Income Strategy ETF | -34.23% | -5.31% |
BIB ProShares Ultra Nasdaq Biotechnology | 21.11% | 38.05% |
Correlation
The correlation between RDYY and BIB is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Sep 9, 2025 | 0.18 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RDYY vs. BIB — Risk / Return Rank
RDYY
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
BIB
RDYY vs. BIB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for YieldMax RDDT Option Income Strategy ETF (RDYY) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RDYY | BIB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.34 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 5.48 | — |
| Martin ratioReturn relative to average drawdown | — | 15.43 | — |
Loading charts...
Drawdowns
RDYY vs. BIB - Drawdown Comparison
The maximum RDYY drawdown since its inception was -51.16%, smaller than the maximum BIB drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for RDYY and BIB.
Loading charts...
Drawdown Indicators
| RDYY | BIB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.16% | -67.24% | +16.08% |
Max Drawdown (1Y)Largest decline over 1 year | — | -16.92% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -45.30% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -65.86% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -66.20% | — |
Current DrawdownCurrent decline from peak | -43.91% | -12.04% | -31.87% |
Average DrawdownAverage peak-to-trough decline | -28.88% | -32.55% | +3.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 6.00% | — |
Volatility
RDYY vs. BIB - Volatility Comparison
Loading charts...
Volatility by Period
| RDYY | BIB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 12.15% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 31.41% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 58.45% | 40.57% | +17.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.45% | 43.72% | +14.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.45% | 46.29% | +12.16% |
RDYY vs. BIB - Expense Ratio Comparison
RDYY has a 0.99% expense ratio, which is higher than BIB's 0.95% expense ratio.
Dividends
RDYY vs. BIB - Dividend Comparison
RDYY's dividend yield for the trailing twelve months is around 133.67%, more than BIB's 0.33% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.33% | 0.77% | 1.69% | 0.07% | 0.03% |
RDYY YieldMax RDDT Option Income Strategy ETF | 133.67% | 25.20% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RDYY and BIB have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BIB is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BIB is cheaper with a 0.95% expense ratio, compared with 0.99% for RDYY.
RDYY has the higher dividend yield at 133.67%, compared with 0.33% for BIB.
RDYY is categorized as Derivative Income, while BIB is Leveraged Equities. They also come from different issuers: YieldMax and ProShares. Their fees differ too: 0.99% for RDYY and 0.95% for BIB.
Find the right allocation for RDYY and BIB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer